Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador ; volume:17 ; number:1 ; day:29 ; month:7 ; year:2020 ; pages:1-5 ; date:12.2020
AIDS research and therapy ; 17, Heft 1 (29.7.2020), 1-5, 12.2020
- Creator
-
Checa, Alejandro
Castillo, Alberto
Camacho, Malena
Tapia, William
Hernandez, Isabel
Teran, Enrique
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-020-00303-1
- URN
-
urn:nbn:de:101:1-2020092523341373559264
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Checa, Alejandro
- Castillo, Alberto
- Camacho, Malena
- Tapia, William
- Hernandez, Isabel
- Teran, Enrique
- SpringerLink (Online service)
Other Objects (12)
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz